(Q42956247)

English

Improved survival in thalassemia major patients on switching from desferrioxamine to combined chelation therapy with desferrioxamine and deferiprone

scientific article published on 8 October 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

Improved survival in thalassemia major patients on switching from desferrioxamine to combined chelation therapy with desferrioxamine and deferiprone (English)

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

chelation therapy

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Paul T Telfer

1

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

Fiona Warburton

2

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

Soteroula Christou

3

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

Michael Hadjigavriel

4

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

Maria Sitarou

5

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

Anita Kolnagou

6

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

Michael Angastiniotis

7

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

publication date

8 October 2009

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

94

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

12

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

1777-1778

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2791948

26 May 2018

Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2791948

26 May 2018

A randomized controlled 1-year study of daily deferiprone plus twice weekly desferrioxamine compared with daily deferiprone monotherapy in patients with thalassemia major

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2791948

16 August 2018

Survival of medically treated thalassemia patients in Cyprus. Trends and risk factors over the period 1980-2004.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2791948

16 August 2018

Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2791948

16 August 2018

Iron chelation treatment with combined therapy with deferiprone and deferioxamine: a 12-month trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2791948

16 August 2018

Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2791948

16 August 2018

Combined therapy with deferiprone and desferrioxamine

1 reference

https://pubmed.ncbi.nlm.nih.gov/19815834

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined therapy with deferiprone and desferrioxamine in thalassemia major

1 reference

https://pubmed.ncbi.nlm.nih.gov/19815834

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival in beta-thalassaemia major in the UK: data from the UK Thalassaemia Register

1 reference

https://pubmed.ncbi.nlm.nih.gov/19815834

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3324/HAEMATOL.2009.009118

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42956247&oldid=1975052358"